Dermatology · Avon, IN
NPI
1619963998
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8244 E US Highway 36, Suite 1220
Avon, IN, 46123
Phone (317) 272-1366
Groups this clinician bills Medicare through
Medicare paid, 2024
$499K
7,275 services
Medicare patients, 2024
564
Average age 76
Drug cost, 2024
$224K
2,355 prescriptions
Company payments, 2025
$722
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Nathan was code 88305 (surgical pathology examination), 2,479 times for 400 patients. In total David L Nathan billed 7,275 services in 34 codes, and Medicare paid $499K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 2,479 | 400 | $28.46 | $71K |
| 99213 Office E&M - Established | Office | 1,718 | 536 | $65.14 | $112K |
| 17004 Destruction Skin Lesion | Office | 824 | 343 | $119.49 | $98K |
| 11103 Skin Biopsy | Office | 587 | 214 | $37.78 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 460 | 53 | $0.08 | $35.92 |
| 11102 Skin Biopsy | Office | 268 | 222 | $69.51 | $19K |
| 11106 Skin Biopsy | Office | 192 | 164 | $117.71 | $23K |
| 99203 Office E&M - New | Office | 136 | 135 | $78.96 | $11K |
| 96372 Injection Administration | Office | 124 | 57 | $10.10 | $1,252 |
| 11104 Skin Biopsy | Office | 89 | 78 | $87.32 | $7,772 |
| 14041 Skin Grafting | Office | 75 | 60 | $710.36 | $53K |
| 11105 Skin Biopsy | Office | 74 | 57 | $44.52 | $3,294 |
| 11107 Skin Biopsy | Office | 69 | 55 | $55.95 | $3,861 |
| 14021 Skin Grafting | Office | 40 | 37 | $679.32 | $27K |
| 14061 Skin Grafting | Office | 22 | 22 | $783.90 | $17K |
By year: 2022 $478K for 7,653 services; 2023 $442K for 7,166 services; 2024 $499K for 7,275 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 2,479 | 400 | $28.46 | $71K |
Medicare prescription drug claims, 2024
In 2024, the drug David L Nathan prescribed most often to Medicare patients was Cephalexin, with 378 prescriptions and refills. In total David L Nathan wrote 2,355 Medicare prescriptions that cost $224K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 378 | 483 | 211 | $8,522 |
| Triamcinolone Acetonide Generic | 343 | 462 | 220 | $5,570 |
| Prednisone Generic | 278 | 282 | 98 | $903 |
| Betamethasone Dipropionate Generic | 180 | 244 | 96 | $7,852 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 143 | 143 | 116 | $901 |
| Ketoconazole Generic | 100 | 131 | 52 | $1,687 |
| Mupirocin Generic | 99 | 102 | 60 | $696 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 90 | 126 | 49 | $2,372 |
| Hydroxyzine Hcl Generic | 90 | 143 | 38 | $1,629 |
| Terbinafine Hcl Generic | 57 | 97 | 20 | $751 |
| Minoxidil Generic | 47 | 125 | 18 | $824 |
| Minocycline Hcl Generic | 42 | 74 | 22 | $2,197 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 32 | 51 | 22 | $544 |
| Metronidazole Generic | 32 | 47 | 20 | $1,742 |
| Fluconazole Generic | 29 | 31 | 11 | $340 |
Brand drugs: 46 claims; generic drugs: 2,309 claims; opioid claims: 186.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Nathan $722 ($722 in general payments such as food, travel and fees) from 12 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $258.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $258 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $105 |
| Abbvie Inc. ABBV | 5 | $92.07 |
| Janssen Biotech, Inc. JNJ | 3 | $70.05 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $64.03 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $26.9 |
| UCB, Inc. UCB.BR | 1 | $26.1 |
| Verrica Pharmaceuticals Inc. VRCA | 1 | $19.39 |
| Pfizer Inc. PFE | 1 | $17.66 |
| LEO Pharma Inc. | 1 | $16.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.